IOVA icon

Iovance Biotherapeutics

283 hedge funds and large institutions have $2.2B invested in Iovance Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 108 increasing their positions, 83 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% less funds holding

Funds holding: 294283 (-11)

5.85% less ownership

Funds ownership: 83.09%77.24% (-5.8%)

19% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 47

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$44.1M
Puts
$24.7M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
201
$145K
202
$144K
203
$142K
204
$141K
205
$137K
206
$136K
207
$135K
208
$128K
209
$121K
210
$121K
211
$119K
212
$115K
213
$105K
214
$103K
215
$100K
216
$97.7K
217
$97.3K
218
$95.8K
219
$94.4K
220
$94.3K
221
$93K
222
$88.6K
223
$81.7K
224
$81K
225
$78K